CLINICAL_TRIALS trial_result · 2017-04-14

Clinical Trial Update: A Study of Olaratumab in Soft Tissue Sarcoma [Phase 1, Phase 2]

This is a Phase 1/2 clinical trial evaluating olaratumab in patients with soft tissue sarcoma; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Sarcoma, Soft Tissue | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-04-14